Search Results

Agreement of point-of-care prothrombin and activated partial thromboplastin time in dogs with a reference laboratory.

• Authors : Yang W; The Animal Hospital Murdoch University, Murdoch Dr, Murdoch, Western Australia 6150, Australia.; Hosgood G

Subjects: Dog Diseases/Dog Diseases/Dog Diseases/*diagnosis ; Partial Thromboplastin Time/Partial Thromboplastin Time/Partial Thromboplastin Time/*veterinary ; Point-of-Care Systems/Point-of-Care Systems/Point-of-Care Systems/*standards

• Source: Australian veterinary journal [Aust Vet J] 2018 Oct; Vol. 96 (10), pp. 379-384.Publisher: Wiley-Blackwell Pub Country of Publication: England NLM ID: 0370616 Publication Model: Print Cited Medium: Internet ISSN: 1751-0813

Record details

Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer.

• Authors : Shirts BH; Department of Pathology, University of Utah Medical Center, Salt Lake City, UT 84124, USA; Rodgers GM

Subjects: Partial Thromboplastin Time* ; Prothrombin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*blood

• Source: Thrombosis research [Thromb Res] 2012 Sep; Vol. 130 (3), pp. e134-8. Date of Electronic Publication: 2012 Apr 28.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparin.

• Authors : Brack MJ; Academic Department of Cardiology, Glenfield General Hospital, Leicester, UK.; More RS

Subjects: Partial Thromboplastin Time*; Coronary Disease/Coronary Disease/Coronary Disease/*blood ; Drug Monitoring/Drug Monitoring/Drug Monitoring/*standards

• Source: International journal of cardiology [Int J Cardiol] 1993 Jan; Vol. 38 (1), pp. 57-61.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print Cited Medium: Print ISSN: 0167-5273 (Print)

Record details

Effects of DOAC‐Stop on clot waveform analysis of plasma spiked with antithrombin‐dependent and antithrombin‐independent anticoagulants.

• Authors : Ozaki, Yuko¹; Wakui, Masatoshi² ; Oka, Shusaku¹

Subjects: *THROMBOSIS; *PARTIAL thromboplastin time; *THROMBOPLASTIN

• Source: International Journal of Laboratory Hematology. Dec2023, Vol. 45 Issue 6, p979-983. 5p.

Record details

[EXPERIENCES WITH PARTIAL THROMBOPLASTIN TIME TEST].

• Authors : UKITA M; NISHI A; FUJIMAKI M

Subjects: Blood Coagulation Tests* ; Hemophilia A* ; Partial Thromboplastin Time*

• Source: Rinsho byori. The Japanese journal of clinical pathology [Rinsho Byori] 1964 Feb; Vol. 12, pp. 170-2.Publisher: Nihon Rinsho Byori Gakkai Country of Publication: Japan NLM ID: 2984781R Publication Model: Print Cited Medium: Print ISSN: 0047-1860

Record details

The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis.

• Authors : Lunghi B; Cini M; Legnani C

Subjects: Factor XI Deficiency/Factor XI Deficiency/Factor XI Deficiency/*blood ; Factor XI Deficiency/Factor XI Deficiency/Factor XI Deficiency/*genetics ; Partial Thromboplastin Time/Partial Thromboplastin Time/Partial Thromboplastin Time/*statistics & numerical data

• Source: Thrombosis research [Thromb Res] 2012 Sep; Vol. 130 (3), pp. 563-4. Date of Electronic Publication: 2012 May 25.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab.

• Authors : Nusrat, Sanober¹ (AUTHOR) ; Tewari, Sayani² (AUTHOR); Khan, Osman³ (AUTHOR)

Subjects: *RITUXIMAB; *PARTIAL thromboplastin time; *ANTIPHOSPHOLIPID syndrome

• Source: Thrombosis Journal. 7/17/2023, Vol. 21, p1-4. 4p.

Record details

Test Cuvettes, Bio-ksel System Aptts (activated Partial Thromboplastin Time), Bio-ksel Pt Plus (prothrombin Time), Bio-ksel Normal Control Systems, Reagent (solvent) Bio-ksel System Diluent (50 Ml.) B.

• Source: Mena Report. 2024.

Record details

OPTIMIZATION OF THE EVALUATION METHOD OF THE PERFORMANCE OF THERAPY USING INDIRECT ACTION ANTICOAGULANTS.

• Authors : Korolova, D. S.¹; Hornytska, O. V.¹; Deyev, V. A.²

Subjects: *PARTIAL thromboplastin time; *VENOM; *BLOOD plasma

• Source: Biotechnologia Acta. 2022, Vol. 15 Issue 3, p1-2. 2p.

Record details

In vitro evaluation of hyperosmotic canine plasma suitable for infusion.

• Authors : Edwards, Thomas H.^1,2,3 (AUTHOR) ; Meledeo, Michael A.¹ (AUTHOR); Peltier, Grantham C.¹ (AUTHOR)

Subjects: *BLOOD coagulation factors; *PARTIAL thromboplastin time; *PROTHROMBIN time

• Source: Journal of Veterinary Emergency & Critical Care. Jan2024, Vol. 34 Issue 1, p63-68. 6p.

Record details